Showing results (161-170 of 209) with videos related to

Sort By:
Pageof 21
Brain Pathology (Zurich, Switzerland)|June 15, 2022
Endoplasmic reticulum-stress and unfolded protein response-activation in immune-mediated necrotizing myopathyCorinna Preusse, Theodore Marteau, Norina Fischer, et al.
Brain : a Journal of Neurology|February 11, 2022
NCAM1 and GDF15 are biomarkers of Charcot-Marie-Tooth disease in patients and miceMatthew J Jennings, Alexia Kagiava, Leen Vendredy, et al.
Skeletal Muscle|February 12, 2026
Unveiling FLNC variants: iPSC-derived myogenic cells as a model to study disease mechanismsNassam M Daya, Anne Schänzer, Andreas Hentschel, et al.
International Journal of Molecular Sciences|November 27, 2024
Identification of Biochemical Determinants for Diagnosis and Prediction of Severity in 5q Spinal Muscular Atrophy Using <sup>1</sup>H-Nuclear Magnetic Resonance Metabolic Profiling in Patient-Derived BiofluidsAfshin Saffari, Moritz Niesert, Claire Cannet, et al.
Acta Neuropathologica Communications|February 13, 2025
Blood biomarker fingerprints in a cohort of patients with CHRNE-related congenital myasthenic syndromeAdela Della Marina, Andrie Koutsoulidou, Daniel Natera-de Benito, et al.
Acta Neuropathologica|July 16, 2024
Anti-Ku + myositis: an acquired inflammatory protein-aggregate myopathyMarie-Therese Holzer, Akinori Uruha, Andreas Roos, et al.
Journal of Neurology|January 23, 2026
Exploring molecular signatures in PURA syndrome using muscle proteomics and serum biomarkersMagdalena Mroczek, Corinna Preusse, Andreas Hentschel, et al.
Orphanet Journal of Rare Diseases|October 21, 2021
<sup>1</sup>H-NMR-based metabolic profiling identifies non-invasive diagnostic and predictive urinary fingerprints in 5q spinal muscular atrophyAfshin Saffari, Claire Cannet, Astrid Blaschek, et al.
JAMA Network Open|April 8, 2024
Application of the Universal Definition of Myocardial Infarction in Clinical Practice in Scotland and SwedenCaelan Taggart, Andreas Roos, Erik Kadesjö, et al.
Ebiomedicine|July 3, 2024
Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clusteringChristopher Nelke, Christina B Schroeter, Sumanta Barman, et al.
Pageof 21